DEBRISOQUINE HYDROXYLATION CAPACITY - PROBLEMS OF ASSESSMENT IN 2 POPULATIONS

被引：44

作者：

INABA, T ^{[1
]}

OTTON, SV ^{[1
]}

KALOW, W ^{[1
]}

机构：

[1] UNIV TORONTO, FAC MED, DEPT PHARMACOL, TORONTO M5S 1A8, ONTARIO, CANADA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1981年 / 29卷 / 02期

关键词：

D O I：

10.1038/clpt.1981.35

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：218 / 223

页数：6

共 17 条

[1] ABRAMS WB, 1969, CLIN PHARMACOL THER, V10, P702
[2] INDIVIDUAL-DIFFERENCES IN DISPOSITION OF DRUGS METABOLIZED IN BODY
ALVAN, G
[J]. CLINICAL PHARMACOKINETICS, 1978, 3 (02) : 155 - 175
[3] UPTAKE OF DEBRISOQUIN AND GUANETHIDINE BY HUMAN BLOOD PLATELETS
BOULLIN, DJ
OBRIEN, RA
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1968, 20 (05) : 403 - &
[4] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT
EICHELBAUM, M
SPANNBRUCKER, N
STEINCKE, B
DENGLER, HJ
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) : 183 - 187
[5] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION
EVANS, DAP
MAHGOUB, A
SLOAN, TP
IDLE, JR
SMITH, RL
[J]. JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) : 102 - 105
[6] DEFICIENT METABOLISM OF DEBRISOQUINE AND SPARTEINE
INABA, T
OTTON, SV
KALOW, W
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) : 547 - 549
[7] KALOW W, 1979, CLIN PHARMACOL THER, V26, P766
[8] ETHNIC DIFFERENCE IN DRUG-METABOLISM - DEBRISOQUINE 4-HYDROXYLATION IN CAUCASIANS AND ORIENTALS
KALOW, W
OTTON, SV
KADAR, D
ENDRENYI, L
INABA, T
[J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1980, 58 (09) : 1142 - 1144
[9] BIOCHEMICAL AND GENETIC FACTORS REGULATING DILANTIN METABOLISM IN MAN
KUTT, H
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) : 704 - &
[10] POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN
MAHGOUB, A
IDLE, JR
DRING, LG
LANCASTER, R
SMITH, RL
[J]. LANCET, 1977, 2 (8038) : 584 - 586

← 1 2 →